Insiders Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 09:07:31 11/05/2026 pm IST			5-day change	1st Jan Change
37.08 ^EUR	+0.27%		-0.86%	+0.19%

11/05	Weekly Earnings Calendar
08/05	BAYER AG : UBS maintains a Buy rating	ZD

Insiders

31/03	Bayer AG Announces Appointment of Nelson Ambrogio as President of U.S. Pharmaceuticals, Effective May 1, 2026	CI
04/03	Bayer Net Loss Widens on Weedkiller Litigation Charges -- Update	DJ
04/03	Bayer Net Loss Widens on Weedkiller Litigation Charges	DJ
23/02	After Takeover: Covestro CEO Announces Departure	DP
23/02	Covestro CEO Steilemann Announces Departure Following Adnoc Takeover	RE
24/11	Bayer shares up more than 8% on revived fortunes for blood thinner	RE
06/11	Bayer AG Appoints Judith Hartmann to the Board of Management, Effective March 1, 2026	CI
06/11	Bayer Names Successor to Outgoing CFO	MT
06/11	Bayer AG - Dr. Judith Hartmann to become new chief financial officer of Bayer AG	RE
16/25/16	Bayer Extends CEO Anderson's Contract Until 2029	RE
16/25/16	Bayer extends contract of CEO until March 2029	RE
16/25/16	Bayer extends contract of CEO until March 2029	RE
16/25/16	Bayer supervisory board extends contract of CEO Bill Anderson	RE
01/25/01	Bayer Announces Executive Changes for North America	CI
04/25/04	Bayer: launches tomatoes resistant to the ToBRV virus
29/25/29	Guru Ramamurthy Appointed As New CFO For Bayer's Crop Science Division	RE
29/25/29	Bayer Announces Changes to CFO for Crop Science Division, Effective July 1, 2025	CI
24/25/24	Bayer Announces Management Changes, Effective April 15, 2025	CI
24/25/24	Bayer: new R&D manager for agrochemicals
23/25/23	Bayer Teams Up with Pula Foundation to Insure Smallholder Farmers in Africa, Asia	MT
29/24/29	Bayer: new CEO for Bayer HealthCare in France
06/24/06	Bayer's operating profit hit by weak agrochemicals demand	RE
06/24/06	Singtel-owned Optus names broadband network boss Stephen Rue as new CEO	RE
10/24/10	Bayer: new Chief Scientific Officer at AskBio
01/24/01	Bayer Appoints Sue Ann Pentecost as Head of U.S. Pharmaceutical Communications	CI